We are live on ! Find out more
Alkeon Capital Management

Alkeon Capital Management Portfolio holdings

AUM $59.5B
1-Year Est. Return 51.63%
This Fund
S&P 500
This Quarter Est. Return
+23.56%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$61.4B
AUM Growth
+$7.43B
Cap. Flow
-$1B
Cap. Flow %
-1.63%
Top 10 Hldgs %
56.32%
Holding
179
New
34
Increased
69
Reduced
34
Closed
16

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$237M
2
TWLO icon
Twilio
TWLO
+$215M
3
GPN icon
Global Payments
GPN
+$177M
4
PINS icon
Pinterest
PINS
+$176M
5
TEAM icon
Atlassian
TEAM
+$167M

Sector Composition

Rank Sector Weight
1 Technology 19.46%
2 Consumer Discretionary 7.5%
3 Communication Services 4.16%
4 Financials 3.26%
5 Healthcare 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABNB icon
126
Airbnb
ABNB
$110B
$29.4M 0.05%
+200,486
New +$29.6M
DLB icon
127
Dolby
DLB
$5.83B
$29.1M 0.05%
+300,000
New +$24.8M
CERE
128
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$29M 0.05%
+1,750,000
New +$22.7M
CRWD icon
129
CrowdStrike
CRWD
$231B
$27.5M 0.04%
+520,000
New +$20.3M
MTCH icon
130
CALL
Match Group
MTCH
$8.43B
$26.5M 0.04%
+175,000
New +$23.1M
YSG
131
Yatsen Holding
YSG
$314M
$26.4M 0.04%
+310,705
New +$26M
RNAM
132
DELISTED
Avidity Biosciences
RNAM
$22.3M 0.04%
875,000
DDOG icon
133
Datadog
DDOG
$92.2B
$21.2M 0.03%
215,000
WB icon
134
PUT
Weibo
WB
$1.97B
$20.5M 0.03%
501,300
+1,300
+0.3% +$54.9K
ZM icon
135
Zoom
ZM
$31.4B
$20.2M 0.03%
60,000
FDMT icon
136
4D Molecular Therapeutics
FDMT
$578M
$16.7M 0.03%
+401,885
New +$16.6M
APLT
137
DELISTED
Applied Therapeutics
APLT
$16.3M 0.03%
739,553
+1,514
+0.2% +$31.5K
ESTC icon
138
Elastic
ESTC
$7.98B
$11.7M 0.02%
+80,000
New +$9.83M
MPWR icon
139
Monolithic Power Systems
MPWR
$68.5B
$11M 0.02%
30,000
RCUS icon
140
Arcus Biosciences
RCUS
$3.67B
$10.6M 0.02%
407,100
-307,745
-43% -$7.45M
MNTV
141
DELISTED
Momentive Global Inc. Common Stock
MNTV
$7.92M 0.01%
+310,000
New +$6.98M
NGNE icon
142
Neurogene
NGNE
$706M
$7.05M 0.01%
25,000
+15,000
+150% +$3.67M
MREO
143
Mereo BioPharma
MREO
$45.5M
$6.93M 0.01%
+1,935,600
New +$4.85M
MORF
144
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$5.03M 0.01%
150,000
U icon
145
Unity
U
$18.7B
$4.14M 0.01%
27,000
-473,000
-95% -$57.5M
TTWO icon
146
Take-Two Interactive
TTWO
$47.3B
$3.31M 0.01%
15,916
-157,306
-91% -$27.5M
TENB icon
147
Tenable Holdings
TENB
$4.23B
$3.14M 0.01%
+60,000
New +$2.38M
GDS icon
148
GDS Holdings
GDS
$6.28B
$2.81M ﹤0.01%
30,000
RLMD icon
149
Relmada Therapeutics
RLMD
$493M
$1.6M ﹤0.01%
+50,000
New +$1.72M
COST icon
150
Costco
COST
$421B
$1.03M ﹤0.01%
2,722

Similar funds

Alkeon Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Alkeon Capital Management held 179 positions worth $61.4B, up 14% from $54B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Alkeon Capital Management's Q4 2020 filing shows 34 new, 69 increased, 34 reduced and 16 closed positions. Its largest new stake was Atlassian: 791,723 shares worth $185M. The largest sale was ASML, an estimated $259M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Alkeon Capital Management's largest Q4 2020 buy was Atlassian: 791,723 shares worth $185M.
  • Alkeon Capital Management added most to Alibaba in Q4 2020, an estimated $237M increase.
  • Alkeon Capital Management's biggest Q4 2020 reduction was Mercado Libre, cutting an estimated $194M.
  • Alkeon Capital Management fully exited ASML in Q4 2020, selling an estimated $259M.
  • Alkeon Capital Management's ten largest holdings make up 56% of its $61.4B portfolio in Q4 2020.
  • Alkeon Capital Management opened 34 new positions and closed 16 in Q4 2020.
  • Alkeon Capital Management's portfolio value rose 14% quarter-over-quarter to $61.4B.

Based on Alkeon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.